News

From Momentum to Movement: Q1 Advocacy Wins & What Comes Next

VETS Legislative Director Logan Davidson recaps Q1 2025's landmark policy wins—from Texas to Georgia—and previews what’s next in the fight for safe, legal access to psychedelic-assisted therapies for veterans. This momentum is real—and the movement is growing.

Opinion: Psychedelic research saved my life. Help it save others.

Retired Green Beret Urges Support for AB 1103 After traditional treatments failed him, a California veteran found healing through psychedelic-assisted therapy. Now, he’s advocating for AB 1103—a bill that would fast-track research on these therapies and expand access for veterans facing PTSD, TBI, and suicidality.

Hawaii Bill To Support Psychedelic Therapy—Passed By Both Senate And House—Is Dead For The Session

Hawaii’s SB 1042, a bill to advance psychedelic-assisted therapy research, made meaningful progress this session with bipartisan support and strong advocacy—including from VETS. Though it missed a procedural deadline, lawmakers aligned on key provisions and plan to reintroduce the measure in 2026, setting the stage for Hawaii to lead on innovative mental health solutions.

Breaking New Ground: Clinical Trials Exploring Psychedelic Therapies for Veterans

For veterans, clinical trials offer a chance to explore healing while contributing to research that could transform care for others. VETS helps you find studies, check eligibility, and get the support you need to participate safely.

Kyrsten Sinema pours campaign money into ASU, veterans groups, payroll

After leaving the Senate, Kyrsten Sinema donated $50,000 to Veterans Exploring Treatment Solutions (VETS), a nonprofit advocating for psychedelic-assisted therapy for veterans with traumatic brain injuries. The donation is part of her broader charitable giving and reflects her continued interest in expanding treatment options for veterans—a cause she championed throughout her time in office.